Average Co-Inventor Count = 2.75
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (6 from 1,323 patents)
2. G.d. Searle LLC (6 from 33 patents)
3. Other (3 from 832,680 patents)
4. Pharmacia Corporation (2 from 200 patents)
5. University of Texas System (1 from 5,444 patents)
6. Monsanto Company (1 from 3,288 patents)
18 patents:
1. 6943189 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors
2. 6890958 - Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
3. 6794396 - Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
4. 6642268 - Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
5. 6638969 - Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
6. 6630572 - Thrombin derived polypeptides: compositions and methods for use
7. 6627731 - Thrombin derived polypeptides; compositions and methods for use
8. 6605624 - Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
9. 6569905 - Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
10. 6562860 - Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
11. 6489366 - Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
12. 6462091 - Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
13. 6458850 - Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
14. 6458851 - Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
15. 6420417 - Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors